China · Delayed Price · Currency is CNY BrightGene Bio-Medical Technology Company Description
BrightGene Bio-Medical Technology Co., Ltd., a pharmaceutical company, engages in the research and development, manufacture, and commercialization of pharmaceutical products in China.
The company offers Eribulin mesylate injection, Voriconazole for injection, Entecavir tablets, Oseltamivir phosphate capsule and dry suspension, Agatroban injection, Mikafungin sodium for injection, Fondaparinux sodium injection, and Caspofungin acetate for injection.
It also provides antitumor, antibodies drug conjugate, anti-infection, angiography, gynecology, cardiovascular, cerebrovascular, iron supplement, digestion, and other APIs and intermediates.
In addition, the company offers veterinary drugs. BrightGene Bio-Medical Technology Co., Ltd. was founded in 2001 and is based in Suzhou, China.
| Country | China |
| Founded | 2001 |
| Industry | Biotechnology |
| Sector | Healthcare |
| Employees | 1,151 |
| CEO | Jiandong Yuan |
Contact Details
Address: Building C25-28 Suzhou, 215123 China | |
| Phone | 86 512 6262 0988 |
| Website | bright-gene.com |
Stock Details
| Ticker Symbol | 688166 |
| Exchange | Shanghai Stock Exchange |
| Fiscal Year | January - December |
| Reporting Currency | CNY |
| ISIN Number | CNE100003PR1 |
| SIC Code | 2836 |
Key Executives
| Name | Position |
|---|---|
| Jiandong Yuan | Chairman and GM |
| Yuanlai Zou | Chief Financial Officer and Director |
| Nan Ding | Board Secretary and Director |
| Kai Li | Deputy General Manager |
| Fangsheng Liu | Accounting Supervisor |